Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria.

Nature medicine·2026
Same author

Task-oriented virtual reality and brain functional plasticity in progressive multiple sclerosis: A randomized controlled trial on upper limb rehabilitation.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Rethinking prognosis in multiple sclerosis: a multiaxial perspective.

Nature reviews. Neurology·2026
Same author

Uncoupling Relapse Reduction and Disability Progression: Evidence From Tolebrutinib Studies.

Neurology. Clinical practice·2026
Same author

Acylcarnitines and prediction of renal function decline in type 2 diabetes.

BMJ open diabetes research & care·2026
Same author

Pediatric sensorimotor cortical responsiveness to intracerebral stimulation during stereoelectroencephalographic monitoring: Age effects and area specificity.

Epilepsia·2026

Related Experiment Video

Updated: Jan 4, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.6K

Predicting disability progression in multiple sclerosis: Insights from advanced statistical modeling.

Fabio Pellegrini1, Massimiliano Copetti2, Maria Pia Sormani3

  • 1Biogen International GmbH, Zug, Switzerland.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|November 6, 2019
PubMed
Summary

Predicting multiple sclerosis (MS) disability progression using baseline clinical factors proved difficult. Advanced statistical models showed poor performance, highlighting the need for new predictors and endpoint definitions.

Keywords:
MS disease progressionPrognostic factor rankingadvanced methodsmodel performancepooled placebo armsrandom forests

More Related Videos

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.5K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.9K

Related Experiment Videos

Last Updated: Jan 4, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.6K
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.5K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.9K

Area of Science:

  • Neurology
  • Biostatistics
  • Clinical Trials

Background:

  • Precise prognosis estimation for multiple sclerosis (MS) remains a challenge.
  • Current methods for predicting MS disability progression require improvement.

Purpose of the Study:

  • To evaluate the prognostic value of clinical measures for disability progression in MS.
  • To assess the predictive performance of advanced statistical models using baseline factors.

Main Methods:

  • Applied advanced statistical models (LASSO, ridge regression, elastic nets, SVM, random forests) to a large pooled sample from MS clinical trials.
  • Modeled time to 24-week confirmed disability progression using baseline prognostic factors.
  • Conducted sensitivity analyses for endpoint definitions and used bootstrap for performance assessment.

Main Results:

  • Included 1582 patients; 27.4% experienced disability progression over 2 years.
  • All models demonstrated poor discrimination performance (C-indices ≤ 0.65).
  • Inconsistent ranking of prognostic factor importance was observed across models.

Conclusions:

  • Baseline clinical factors have limited predictive ability for MS disability progression.
  • The findings underscore the need to explore alternative predictors and endpoint definitions in MS research.